Variable | patients | Alu115 | p | |
---|---|---|---|---|
No. | % | |||
Sex | ||||
male | 46 | 63.01 | 783.75 (521.35–1223.63) | 0.045 |
female | 27 | 36.99 | 1484.50 (414.70–2295.50) | |
AJCC primary tumor | ||||
Tis-T1 | 12 | 16.44 | 818.4 (478.45–1732.75) | 0.724 |
T2 | 12 | 16.44 | 966.9 (432–1496.25) | |
T3 | 5 | 6.85 | 1153.5 (394.00–1238.75) | |
T4 | 44 | 60.27 | 1146.5 (676.7–1878.5) | |
AJCC regional lymph nodes | ||||
N0 | 31 | 42.47 | 1079.5 (408.2–1544) | 0.362 |
N1 | 8 | 10.96 | 1281 (1106–4104.25) | |
N2 | 14 | 19.18 | 1390.5 (606.65–1949.5) | |
N3 | 20 | 27.40 | 925.4 (579.55–2087) | |
AJCC distant metastasis | ||||
M0 | 63 | 86.30 | 1079.5 (552.95–1670) | 0.275 |
M1 | 10 | 13.70 | 1666.5 (754.25–2479.5) | |
AJCC stage | ||||
0-I | 19 | 26.03 | 1027.65 (408.2–1935) | 0.676 |
II | 11 | 15.07 | 1484.5 (400.7–1670) | |
III | 33 | 45.20 | 1065.5 (676.7–1572.5) | |
IV | 10 | 13.70 | 1666.5 (754.25–2479.5) | |
Histopathologic grade | ||||
middle -high | 19 | 26.04 | 906.150 (359.50–1213.00) | 0.811 |
low | 41 | 56.16 | 786.250 (411.45–1586.25) | |
unknow | 13 | 17.81 | ||
Lymphovascular invasion | ||||
positive | 18 | 24.66 | 1190.00 (551.04–1971.88) | 0.653 |
negative | 12 | 16.44 | 1146.50 (400.70–1389.50) | |
unknow | 43 | 58.90 |